Picture of Singular Genomics Systems logo

OMIC Singular Genomics Systems News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

FIGS, Day One Biopharma, Singular Genomics give IPO market a shot in the arm

** Three healthcare-related firms make strong debuts on
Thurs, adding to string of impressive IPOs
    ** Direct-to-consumer medical scrubs maker FIGS Inc's
 FIGS.N  shares jump in debut, and last up ~35% from their $22
IPO price  urn:newsml:reuters.com:*:nL3N2NE4AO
    ** Shares of Day One Biopharmaceuticals  DAWN.O , developer
of pediatric drugs to treat brain cancer, open at $25 after
pricing upsized IPO at $16  urn:newsml:reuters.com:*:nGNX84vvsj
    ** Singular Genomics Systems Inc  OMIC.O  sees its stock
open at $29 vs $22 IPO price, after gene sequencing machines
maker also boosted its deal size  urn:newsml:reuters.com:*:nGNX2l9LGC
    ** This trio of debuts comes on heels of solid IPOs on Weds
by fintechs Flywire  FLYW.O  and Flywire  FLYW.O , as well as
online jobs marketplace ZipRecruiter's  ZIP.N  direct listing,
perhaps setting the stage for resurgence in deal performance
 urn:newsml:reuters.com:*:nL2N2ND23S

 (Lance Tupper is a Reuters market analyst. The views expressed
are his own)
 ((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 1-332-219-1430))

Recent news on Singular Genomics Systems

See all news